These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7988369)

  • 21. Corticoid therapy: how?
    Rubens R
    Bull Soc Belge Ophtalmol; 1990; 236():45-55. PubMed ID: 1965530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of indomethacin on the pharmacokinetics and pharmacodynamics of prednisolone in rats.
    Garg V; Jusko WJ
    J Pharm Sci; 1994 May; 83(5):747-50. PubMed ID: 7915309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin.
    Lee KH; Shin JG; Chong WS; Kim S; Lee JS; Jang IJ; Shin SG
    Eur J Clin Pharmacol; 1993; 45(3):287-9. PubMed ID: 8276057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What do we know about steroids metabolism and 'PK/PD approach' in AKI and CKD especially while on RRT--current status in 2014.
    Honoré PM; Jacobs R; De Waele E; De Regt J; Rose T; Van Gorp V; Joannes-Boyau O; Boer W; Spapen HD
    Blood Purif; 2014; 38(2):154-7. PubMed ID: 25471548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone.
    Yamashita SK; Ludwig EA; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1991 May; 49(5):558-70. PubMed ID: 1827622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor-mediated methylprednisolone pharmacodynamics in rats: steroid-induced receptor down-regulation.
    Haughey DB; Jusko WJ
    J Pharmacokinet Biopharm; 1992 Aug; 20(4):333-55. PubMed ID: 1362219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexistence of glucocorticoid receptor and pharmacokinetic abnormalities: factors that contribute to a poor response to treatment with glucocorticoids in children with asthma.
    Kamada AK; Spahn JD; Surs W; Brown E; Leung DY; Szefler SJ
    J Pediatr; 1994 Jun; 124(6):984-6. PubMed ID: 8201491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of corticosteroid binding globulin on the pharmacokinetics of prednisolone in rats.
    Ko HC; Almon RR; Jusko WJ
    Pharm Res; 1995 Jun; 12(6):902-4. PubMed ID: 7667198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of prednisolone and its local anti-inflammatory steroid-21-oate ester derivatives. In vitro and in vivo comparative study.
    al-Habet SM; Taraporewala IB; Lee HJ
    Drug Metab Dispos; 1990; 18(1):55-60. PubMed ID: 1970778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantitation of prednisolone and dipyridamole in human plasma and its application in a pharmacokinetic study.
    Chen M; Granvil C; Ji QC; Zhang ZY; Padval MV; Kansra VV
    J Pharm Biomed Anal; 2009 Jul; 49(5):1241-9. PubMed ID: 19304431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults.
    Szefler SJ; Ebling WF; Georgitis JW; Jusko WJ
    Eur J Clin Pharmacol; 1986; 30(3):323-9. PubMed ID: 3732369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of methylprednisolone during acute renal allograft rejection.
    Tornatore KM; Walshe JJ; Reed K; Venuto RC
    Clin Transplant; 1995 Apr; 9(2):74-8. PubMed ID: 7599405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexamethasone pharmacokinetics in clinically normal dogs during low- and high-dose dexamethasone suppression testing.
    Greco DS; Brown SA; Gauze JJ; Weise DW; Buck JM
    Am J Vet Res; 1993 Apr; 54(4):580-5. PubMed ID: 8387253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers.
    Booker BM; Magee MH; Blum RA; Lates CD; Jusko WJ
    Clin Pharmacol Ther; 2002 Oct; 72(4):370-82. PubMed ID: 12386639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of glucocorticoid pharmacodynamics in kidney transplantation: difference between prednisolone and methylprednisolone.
    Hirano T; Oka K; Takeuchi H; Kozaki K; Matsuno N; Nagao T; Kozaki M
    Transplantation; 1997 Sep; 64(5):792-3. PubMed ID: 9311727
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.
    Fisher LE; Ludwig EA; Wald JA; Sloan RR; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1992 Jun; 51(6):677-88. PubMed ID: 1535301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and dose linearity testing of methylprednisolone phosphate.
    Möllmann H; Rohdewald P; Barth J; Verho M; Derendorf H
    Biopharm Drug Dispos; 1989; 10(5):453-64. PubMed ID: 2804250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetics of corticosteroid agents.
    Begg EJ; Atkinson HC; Gianarakis N
    Med J Aust; 1987 Jan; 146(1):37-41. PubMed ID: 3540549
    [No Abstract]   [Full Text] [Related]  

  • 39. [Structure and actions of synthetic steroid hormones].
    Umehara S; Sugimoto T
    Nihon Rinsho; 1974 Nov; 32(11):3317-25. PubMed ID: 4616104
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man.
    Wald JA; Law RM; Ludwig EA; Sloan RR; Middleton E; Jusko WJ
    J Pharmacokinet Biopharm; 1992 Dec; 20(6):567-89. PubMed ID: 1302763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.